Richard P.
Richard studied Chemical Engineering at the University of Auckland, and subsequently received his PhD in Materials Science from MIT. He currently works as a technology investor at a venture capital firm.
Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Manasa
Manasa is an MD student at the Perelman School of Medicine at the University of Pennsylvania. She earned her BA in Biochemistry & Molecular Biology at the University of Georgia (Phi Beta Kappa, summa cum laude).